Literature DB >> 11779929

Neuroprotection is unlikely to be effective in humans using current trial designs.

James Grotta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11779929

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  13 in total

1.  Model of reversible cerebral ischemia in a monkey model.

Authors:  Charles A Jungreis; Edwin Nemoto; Fernando Boada; Michael B Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 2.  Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia.

Authors:  H Bart van der Worp; Peter de Haan; Erik Morrema; Cor J Kalkman
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 3.  Why have neuro-protectants failed?: lessons learned from stroke trials.

Authors:  K W Muir; Ph A Teal
Journal:  J Neurol       Date:  2005-08-25       Impact factor: 4.849

4.  Anti-necroptosis chemical necrostatin-1 can also suppress apoptotic and autophagic pathway to exert neuroprotective effect in mice intracerebral hemorrhage model.

Authors:  Pan Chang; Wenwen Dong; Mingyang Zhang; Zufeng Wang; Yaoqi Wang; Tao Wang; Yuan Gao; Huanhuan Meng; Bin Luo; Chengliang Luo; Xiping Chen; Luyang Tao
Journal:  J Mol Neurosci       Date:  2014-02       Impact factor: 3.444

Review 5.  Clinical trial design in the neurocritical care unit.

Authors:  C E Hall; M Mirski; Y Y Palesch; M N Diringer; A I Qureshi; C S Robertson; R Geocadin; C A C Wijman; P D Le Roux; Jose I Suarez
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

6.  Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury.

Authors:  Xingshun Xu; Kao-Wei Chua; Chu C Chua; Chun-Feng Liu; Ronald C Hamdy; Balvin H L Chua
Journal:  Brain Res       Date:  2010-08-01       Impact factor: 3.252

7.  Modeling disease progression in acute stroke using clinical assessment scales.

Authors:  Kristin E Karlsson; Justin J Wilkins; Fredrik Jonsson; Per-Henrik Zingmark; Mats O Karlsson; E Niclas Jonsson
Journal:  AAPS J       Date:  2010-09-21       Impact factor: 4.009

8.  Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.

Authors:  Nicholas J Mulcahy; Jerard Ross; Nancy J Rothwell; Sarah A Loddick
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

9.  Can animal models of disease reliably inform human studies?

Authors:  H Bart van der Worp; David W Howells; Emily S Sena; Michelle J Porritt; Sarah Rewell; Victoria O'Collins; Malcolm R Macleod
Journal:  PLoS Med       Date:  2010-03-30       Impact factor: 11.069

10.  Management of Acute Hypertensive Response in Patients With Ischemic Stroke.

Authors:  Ahmad AlSibai; Adnan I Qureshi
Journal:  Neurohospitalist       Date:  2016-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.